Asia Pacific Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Country: Trend Forecast and Growth Opportunity

August 2020 | 143 pages | ID: A2ED51434387EN
GMD Research

Abstracts

Asia Pacific digital biomarkers market will grow by 34.7% annually with a total addressable market cap of $35.52 billion over 2020-2030 owing to the rising demand for mobile health apps, elevated level of smartphone and wearable technology in healthcare amid COVID-19 epidemic.

Highlighted with 38 tables and 66 figures, this 143-page report “Asia Pacific Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific digital biomarkers market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific digital biomarkers market in every aspect of the classification from perspectives of System Component, Therapeutic Area, Application, Development Status, End User, and Country.

Based on System Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Data Collection Tools

• Digital Platforms
• Mobile Apps
• Desktop-based Software
• Wearables
• Biosensors

Data Integration Systems

Based on Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Cardiovascular Diseases
Neurodegenerative Disorders

• Parkinson’s Disease
• Multiple Sclerosis
• Alzheimer’s Disease

Sleep and Movement Diseases
Psychiatric Disorders
Chronic Pain
Gastrointestinal Diseases
Diabetes
Respiratory Conditions
Other Diseases

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Wellness
• Disease Diagnosis
• Personalised Medication
• Drug Discovery and Development

Based on Development Status, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Novel Digital Biomarkers
• Original Digital Biomarkers
• Approved Digital Biomarkers

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Biopharmaceutical Companies & Labs
• Healthcare Providers
• Insurance Payers

Geographically, the following national/local markets are fully investigated:

• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by System Component, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific digital biomarkers market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
Actigraph LLC
Akili Interactive Labs
AliveCor Inc
Altoida Inc
Amgen Inc
Bayer AG
Biogen Inc
Cambridge Cognition Plc
Eli Lilly and Company
Evidation Health, Inc.
F. Hoffmann-La Roche Ltd
Fitbit Inc
GlaxoSmithKline Plc
Happify Health
Human API
IXICO Plc
Koninklijke Philips N.V.
Medical Care Corporation
Medopad Ltd
Mindstrong Health
Neurotrack Technology, Inc
Novartis International AG
Pfizer Inc.
Quanterix Corporation
Sanofi S.A.
The Takeda Pharmaceuticals Company Limited
Verily Life Sciences
Winterlight Labs Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF ASIA PACIFIC MARKET BY SYSTEM COMPONENT

3.1 Market Overview by System Component
3.2 Data Collection Tools
  3.2.1 Digital Platforms
  3.2.2 Mobile Apps
  3.2.3 Desktop-based Software
  3.2.4 Wearables
  3.2.5 Biosensors
3.3 Data Integration Systems

4 SEGMENTATION OF ASIA PACIFIC MARKET BY THERAPEUTIC AREA

4.1 Market Overview by Therapeutic Area
4.2 Cardiovascular Diseases
4.3 Neurodegenerative Disorders
  4.3.1 Parkinson’s Disease
  4.3.2 Multiple Sclerosis
  4.3.3 Alzheimer’s Disease
4.4 Sleep and Movement Diseases
4.5 Psychiatric Disorders
4.6 Chronic Pain
4.7 Gastrointestinal Diseases
4.8 Diabetes
4.9 Respiratory Conditions
4.10 Other Diseases

5 SEGMENTATION OF ASIA PACIFIC MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Wellness
5.3 Disease Diagnosis
5.4 Personalised Medication
5.5 Drug Discovery and Development

6 SEGMENTATION OF ASIA PACIFIC MARKET BY DEVELOPMENT STATUS

6.1 Market Overview by Development Status
6.2 Novel Digital Biomarkers
6.3 Original Digital Biomarkers
6.4 Approved Digital Biomarkers

7 SEGMENTATION OF ASIA PACIFIC MARKET BY END USER

7.1 Market Overview by End User
7.2 Biopharmaceutical Companies & Labs
7.3 Healthcare Providers
7.4 Insurance Payers

8 ASIA-PACIFIC MARKET 2019-2030 BY COUNTRY

8.1 Overview of Asia-Pacific Market
8.2 Japan
8.3 China
8.4 Australia
8.5 India
8.6 South Korea
8.7 Rest of APAC Region

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Actigraph LLC
Akili Interactive Labs
AliveCor Inc
Altoida Inc
Amgen Inc
Bayer AG
Biogen Inc
Cambridge Cognition Plc
Eli Lilly and Company
Evidation Health, Inc.
F. Hoffmann-La Roche Ltd
Fitbit Inc
GlaxoSmithKline Plc
Happify Health
Human API
IXICO Plc
Koninklijke Philips N.V.
Medical Care Corporation
Medopad Ltd
Mindstrong Health
Neurotrack Technology, Inc
Novartis International AG
Pfizer Inc.
Quanterix Corporation
Sanofi S.A.
The Takeda Pharmaceuticals Company Limited
Verily Life Sciences
Winterlight Labs Inc.

10 INVESTING IN ASIA PACIFIC MARKET: RISK ASSESSMENT AND MANAGEMENT

10.1 Risk Evaluation of Asia Pacific Market
10.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Asia Pacific Digital Biomarkers Market, 2019-2030
Table 2. Overview of Traditional and Digital Biomarker Features, Novel Applications, and Published Examples
Table 3. World Smartphone Connections, Average Network Connection Speed for Smartphones and Tablets, 2019-2030
Table 4. World Mobile Data Traffic by Deployment Mode, 2019-2030, EB/year
Table 5. World Mobile Data Traffic by Device, 2019-2030, EB/year
Table 6. Current Challenges of Digital Biomarkers in Medical Settings
Table 7. Main Product Trends and Market Opportunities in Asia Pacific Digital Biomarkers Market
Table 8. Asia Pacific Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 9. Asia Pacific Digital Biomarkers Market: Data Collection Tools by Type, 2019-2030, $ mn
Table 10. Asia Pacific Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 11. Asia Pacific Digital Biomarkers Market: Neurodegenerative Disorders by Type, 2019-2030, $ mn
Table 12. Asia Pacific Digital Biomarkers Market by Application, 2019-2030, $ mn
Table 13. Asia Pacific Digital Biomarkers Market by Development Status, 2019-2030, $ mn
Table 14. Asia Pacific Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 15. APAC Digital Biomarkers Market by Country, 2019-2030, $ mn
Table 16. Japan Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 17. Japan Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 18. Japan Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 19. China Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 20. China Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 21. China Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 22. Australia Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 23. Australia Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 24. Australia Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 25. India Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 26. India Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 27. India Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 28. South Korea Digital Biomarkers Market by System Component, 2019-2030, $ mn
Table 29. South Korea Digital Biomarkers Market by Therapeutic Area, 2019-2030, $ mn
Table 30. South Korea Digital Biomarkers Market by End User, 2019-2030, $ mn
Table 31. Digital Biomarkers Market in Rest of APAC by Country, 2019-2030, $ mn
Table 32. Actigraph LLC: Company Snapshot
Table 33. Actigraph LLC: Business Segmentation
Table 34. Actigraph LLC: Product Portfolio
Table 35. Actigraph LLC: Revenue, 2016-2018, $ mn
Table 36. Actigraph LLC: Recent Developments
Table 37. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030
Table 38. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Asia Pacific Digital Biomarkers Market, 2019-2030, $ mn
Figure 6. Category and Relationship of Traditional Biomarkers and Digital Biomarkers
Figure 7. Benefits and Challenges of Digital Biomarkers
Figure 8. Asia Pacific Biomarkers Market, 2019-2030, $ mn
Figure 9. Share of Digital Biomarkers in Total Biomarkers Market, 2019-2030
Figure 10. Impact of COVID-19 on Business
Figure 11. Primary Drivers and Impact Factors of Asia Pacific Digital Biomarkers Market
Figure 12. World 5G Traffic, 2019-2030, EB/year
Figure 13. Primary Restraints and Impact Factors of Asia Pacific Digital Biomarkers Market
Figure 14. Data Security Risk in Various User Groups of Digital Biomarkers
Figure 15. Pathway to Regulatory Approval of Digital Biomarkers
Figure 16. Investment Opportunity Analysis
Figure 17. Porter’s Fiver Forces Analysis of Asia Pacific Digital Biomarkers Market
Figure 18. Breakdown of Asia Pacific Digital Biomarkers Market by System Component, 2019-2030, % of Revenue
Figure 19. Asia Pacific Addressable Market Cap in 2020-2030 by System Component, Value ($ mn) and Share (%)
Figure 20. Asia Pacific Digital Biomarkers Market: Data Collection Tools, 2019-2030, $ mn
Figure 21. Asia Pacific Digital Biomarkers Market: Digital Platforms, 2019-2030, $ mn
Figure 22. Asia Pacific Digital Biomarkers Market: Mobile Apps, 2019-2030, $ mn
Figure 23. Asia Pacific Digital Biomarkers Market: Desktop-based Software, 2019-2030, $ mn
Figure 24. Asia Pacific Digital Biomarkers Market: Wearables, 2019-2030, $ mn
Figure 25. Asia Pacific Digital Biomarkers Market: Biosensors, 2019-2030, $ mn
Figure 26. Asia Pacific Digital Biomarkers Market: Data Integration Systems, 2019-2030, $ mn
Figure 27. Breakdown of Asia Pacific Digital Biomarkers Market by Therapeutic Area, 2019-2030, % of Sales Revenue
Figure 28. Asia Pacific Addressable Market Cap in 2020-2030 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 29. Asia Pacific Digital Biomarkers Market: Cardiovascular Diseases, 2019-2030, $ mn
Figure 30. Asia Pacific Digital Biomarkers Market: Neurodegenerative Disorders, 2019-2030, $ mn
Figure 31. Asia Pacific Digital Biomarkers Market: Parkinson’s Disease, 2019-2030, $ mn
Figure 32. Asia Pacific Digital Biomarkers Market: Multiple Sclerosis, 2019-2030, $ mn
Figure 33. Asia Pacific Digital Biomarkers Market: Alzheimer’s Disease, 2019-2030, $ mn
Figure 34. Asia Pacific Digital Biomarkers Market: Sleep and Movement Diseases, 2019-2030, $ mn
Figure 35. Asia Pacific Digital Biomarkers Market: Psychiatric Disorders, 2019-2030, $ mn
Figure 36. Asia Pacific Digital Biomarkers Market: Chronic Pain, 2019-2030, $ mn
Figure 37. Asia Pacific Digital Biomarkers Market: Gastrointestinal Diseases, 2019-2030, $ mn
Figure 38. Asia Pacific Digital Biomarkers Market: Diabetes, 2019-2030, $ mn
Figure 39. Asia Pacific Digital Biomarkers Market: Respiratory Conditions, 2019-2030, $ mn
Figure 40. Asia Pacific Digital Biomarkers Market: Other Diseases, 2019-2030, $ mn
Figure 41. Breakdown of Asia Pacific Digital Biomarkers Market by Application, 2019-2030, % of Sales Revenue
Figure 42. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 43. Asia Pacific Digital Biomarkers Market: Wellness, 2019-2030, $ mn
Figure 44. Asia Pacific Digital Biomarkers Market: Disease Diagnosis, 2019-2030, $ mn
Figure 45. Asia Pacific Digital Biomarkers Market: Personalised Medication, 2019-2030, $ mn
Figure 46. Asia Pacific Digital Biomarkers Market: Drug Discovery and Development, 2019-2030, $ mn
Figure 47. Classification of Digital Biomarkers by Development Status
Figure 48. Breakdown of Asia Pacific Digital Biomarkers Market by Development Status, 2019-2030, % of Revenue
Figure 49. Asia Pacific Addressable Market Cap in 2020-2030 by Development Status, Value ($ mn) and Share (%)
Figure 50. Asia Pacific Digital Biomarkers Market: Novel Digital Biomarkers, 2019-2030, $ mn
Figure 51. Asia Pacific Digital Biomarkers Market: Original Digital Biomarkers, 2019-2030, $ mn
Figure 52. Asia Pacific Digital Biomarkers Market: Approved Digital Biomarkers, 2019-2030, $ mn
Figure 53. Breakdown of Asia Pacific Digital Biomarkers Market by End User, 2019-2030, % of Revenue
Figure 54. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 55. Asia Pacific Digital Biomarkers Market: Biopharmaceutical Companies & Labs, 2019-2030, $ mn
Figure 56. Asia Pacific Digital Biomarkers Market: Healthcare Providers, 2019-2030, $ mn
Figure 57. Asia Pacific Digital Biomarkers Market: Insurance Payers, 2019-2030, $ mn
Figure 58. Breakdown of APAC Digital Biomarkers Market by Country, 2019 and 2030, % of Revenue
Figure 59. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 60. Digital Biomarkers Market in Japan, 2019-2030, $ mn
Figure 61. Digital Biomarkers Market in China, 2019-2030, $ mn
Figure 62. Digital Biomarkers Market in Australia, 2019-2030, $ mn
Figure 63. Digital Biomarkers Market in India, 2019-2030, $ mn
Figure 64. Digital Biomarkers Market in South Korea, 2019-2030, $ mn
Figure 65. Digital Biomarkers Market in Rest of APAC, 2019-2030, $ mn
Figure 66. Growth Stage of Asia Pacific Digital Biomarkers Industry over the Forecast Period


COMPANIES MENTIONED

Actigraph LLC
Akili Interactive Labs
AliveCor Inc
Altoida Inc
Amgen Inc
Bayer AG
Biogen Inc
Cambridge Cognition Plc
Eli Lilly and Company
Evidation Health, Inc.
F. Hoffmann-La Roche Ltd
Fitbit Inc
GlaxoSmithKline Plc
Happify Health
Human API
IXICO Plc
Koninklijke Philips N.V.
Medical Care Corporation
Medopad Ltd
Mindstrong Health
Neurotrack Technology, Inc
Novartis International AG
Pfizer Inc.
Quanterix Corporation
Sanofi S.A.
The Takeda Pharmaceuticals Company Limited
Verily Life Sciences
Winterlight Labs Inc.